NDAORALTABLET, EXTENDED RELEASEPriority Review
Approved
Jan 2010
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Mechanism of Action
Potassium Channel Antagonists
Pharmacologic Class:
Potassium Channel Blocker
Clinical Trials (2)
FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra
Started Jun 2012
108 enrolled
Multiple Sclerosis
An Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra (BIIB041) When Used In Routine Medical Practice
Started Apr 2012
4,734 enrolled
Multiple Sclerosis